These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31145316)

  • 21. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis.
    Hollis C; Pennant M; Cuenca J; Glazebrook C; Kendall T; Whittington C; Stockton S; Larsson L; Bunton P; Dobson S; Groom M; Hedderly T; Heyman I; Jackson GM; Jackson S; Murphy T; Rickards H; Robertson M; Stern J
    Health Technol Assess; 2016 Jan; 20(4):1-450, vii-viii. PubMed ID: 26786936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy, safety and tolerability of aripiprazole in bipolar disorder: An updated systematic review and meta-analysis of randomized controlled trials.
    Li DJ; Tseng PT; Stubbs B; Chu CS; Chang HY; Vieta E; Fornaro M; Carvalho AF; Solmi M; Veronese N; Chen TY; Chen YW; Lin PY; Chow PC
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):289-301. PubMed ID: 28651936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aripiprazole for schizophrenia.
    El-Sayeh HG; Morganti C
    Cochrane Database Syst Rev; 2004; (2):CD004578. PubMed ID: 15106256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).
    Powney MJ; Adams CE; Jones H
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009377. PubMed ID: 23152276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders.
    Yoo HK; Choi SH; Park S; Wang HR; Hong JP; Kim CY
    J Clin Psychiatry; 2007 Jul; 68(7):1088-93. PubMed ID: 17685747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness and Tolerability of Aripiprazole in Children and Adolescents with Tourette's Disorder: A Meta-Analysis.
    Liu Y; Ni H; Wang C; Li L; Cheng Z; Weng Z
    J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):436-41. PubMed ID: 26914764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials.
    Marder SR; McQuade RD; Stock E; Kaplita S; Marcus R; Safferman AZ; Saha A; Ali M; Iwamoto T
    Schizophr Res; 2003 Jun; 61(2-3):123-36. PubMed ID: 12729864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.
    Pagsberg AK; Jeppesen P; Klauber DG; Jensen KG; Rudå D; Stentebjerg-Olesen M; Jantzen P; Rasmussen S; Saldeen EA; Lauritsen MG; Bilenberg N; Stenstrøm AD; Nyvang L; Madsen S; Werge TM; Lange T; Gluud C; Skoog M; Winkel P; Jepsen JRM; Fagerlund B; Correll CU; Fink-Jensen A
    Lancet Psychiatry; 2017 Aug; 4(8):605-618. PubMed ID: 28599949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aripiprazole for schizophrenia.
    El-Sayeh HG; Morganti C
    Cochrane Database Syst Rev; 2006 Apr; (2):CD004578. PubMed ID: 16625607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can Aripiprazole Worsen Psychosis in Schizophrenia? A Meta-Analysis of Double-Blind, Randomized, Controlled Trials.
    Takeuchi H; Fathi A; Thiyanavadivel S; Agid O; Remington G
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29570965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China.
    Cui YH; Zheng Y; Yang YP; Liu J; Li J
    J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):291-8. PubMed ID: 20807067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxycodone for cancer-related pain.
    Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD003870. PubMed ID: 28829910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of aripiprazole augmentation of clozapine in schizophrenia: a systematic review and meta-analysis of randomized-controlled trials.
    Srisurapanont M; Suttajit S; Maneeton N; Maneeton B
    J Psychiatr Res; 2015 Mar; 62():38-47. PubMed ID: 25619176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical effectiveness of aripiprazole in short-term treatment of tic disorder in children and adolescents: a naturalistic study.
    Ho CS; Chiu NC; Tseng CF; Huang YL
    Pediatr Neonatol; 2014 Feb; 55(1):48-52. PubMed ID: 23920131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders.
    Yoo HK; Lee JS; Paik KW; Choi SH; Yoon SJ; Kim JE; Hong JP
    Eur Child Adolesc Psychiatry; 2011 Mar; 20(3):127-35. PubMed ID: 21188439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aripiprazole versus risperidone for treating children and adolescents with tic disorder: a randomized double blind clinical trial.
    Ghanizadeh A; Haghighi A
    Child Psychiatry Hum Dev; 2014 Oct; 45(5):596-603. PubMed ID: 24343476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults.
    Sutherland A; Naessens K; Plugge E; Ware L; Head K; Burton MJ; Wee B
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD012555. PubMed ID: 30246876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials.
    Galling B; Roldán A; Rietschel L; Hagi K; Walyzada F; Zheng W; Cao XL; Xiang YT; Kane JM; Correll CU
    Expert Opin Drug Saf; 2016 May; 15(5):591-612. PubMed ID: 26967126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aripiprazole-Induced Hoarseness: A Case Report.
    Işik Ü; Çam Ray P
    Clin Neuropharmacol; 2019; 42(2):55-56. PubMed ID: 30724787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of Opioids in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis.
    Fuggle N; Curtis E; Shaw S; Spooner L; Bruyère O; Ntani G; Parsons C; Conaghan PG; Corp N; Honvo G; Uebelhart D; Baird J; Dennison E; Reginster JY; Cooper C
    Drugs Aging; 2019 Apr; 36(Suppl 1):129-143. PubMed ID: 31073926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.